SCHEMBL24477485

SCHEMBL24477485

Cc1ccnc2c(C(=O)NCCc3ccc(-c4ccco4)cc3)cnn12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.52
KDM4E B2RXH2 3/20 0.52
HPGD P15428 2/20 0.52
ADORA3 P0DMS8 9/20 0.51
ADORA2A P29274 9/20 0.51
ADORA1 P30542 7/20 0.51
ADORA2B P29275 1/20 0.51
MEN1 O00255 1/20 0.45
POLB P06746 1/20 0.45
ALOX15 P16050 1/20 0.45
CASP1 P29466 1/20 0.45
BLM P54132 1/20 0.45
CASP7 P55210 1/20 0.45
KMT2A Q03164 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
HSD17B10 Q99714 1/20 0.45
CCNA2 P20248 1/20 0.44
CDK2 P24941 1/20 0.44
MAPT P10636 2/20 0.44
HKDC1 Q2TB90 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24477482 0.90 PDPK1 (0.54) ALDH1A1KDM4EHPGDADORA3ADORA2A
SCHEMBL24477300 0.87 ALDH1A1 (0.72) ALDH1A1KDM4EHPGDADORA3ADORA2A
SCHEMBL24477484 0.80 KDM4E (0.49) ALDH1A1KDM4EHPGDADORA3ADORA2A
SCHEMBL22472774 0.80 ALDH1A1 (0.42) ALDH1A1KDM4EHPGDADORA3ADORA2A
SCHEMBL24477299 0.77 ALDH1A1 (0.71) ALDH1A1KDM4EHPGDADORA3ADORA2A
SCHEMBL24477483 0.76 ALDH1A1 (0.43) ALDH1A1KDM4EHPGDMEN1POLB
SCHEMBL22767220 0.73 HSD11B1 (0.42) ALDH1A1KDM4EHPGDMEN1POLB
SCHEMBL22472783 0.72 ALDH1A1 (0.44) ALDH1A1KDM4EHPGDADORA3ADORA2A
SCHEMBL24477486 0.71 GSK3A (0.48) ALDH1A1KDM4EHPGDPOLBCASP1
SCHEMBL22767520 0.70 HSD11B1 (0.44) ALDH1A1KDM4EHPGDHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220169652-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS LYSOSOMAL THERAPEUTICS INC. 2022-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220169652-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS PARK7, PNP, GAA ALDH1A1 1213/4885KDM4E 899/4885HPGD 1396/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.